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IN'l'HOP!JC1'ION

filth the recent development of a rapid and reliable
method for the determination of the enzyme, Glutamic Oxalacetic
'l'ransaJ'l11.na.se (GO-I}.'), oonsiderable interest has been aroused In
the olinical implications of increased levels of this enzyme in
human and animal sera during oertain pathological states. GO-T
serves as a catalyst for the reversible reaotion oi" a.lpha-ketoglutarate and I-aspartate to produce oxa1acetate and I-glutamate.
It is widely dIstributed in anImal and human tissues but its
greatest activity has been found in homogenates ot heart musole,
skeletal muscle, braln, liver, kidney, testis, lung and spleen,
in decreaslng order (15) (14). The enzyme has also been found in
all sera that have been tested (27) (63) and 1n normal human
serum the range Is from 8 to 40 unIts with a mean of 22.1 unIts
and a standard deviation or :!:. 6.8 units (33) (45). 'rhe definition
of a unit is g'lven on page 4 of the thesis. Seru.'1.l Glutamic Oxalacetic Transam1nase (SOO-'1') hms been found to be species specific
and In rats the normal range is from 170 to 350 un1ts (45).
while 1n the mouse it v8.ries from 50 to 125 units (21). In the
human, normal urine oontains less than 1 un1t of SOO-T (58).
Methods tor the Determination c,f Transam1pas6 ActivltI
Although it had boen known for more than ten years
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that the SGO-T level varied widely in diseases involving tissues
which oontain high levels of the enzyme, little clinioal work
h.ad been done to correlate these facts until recent years since
all of the methods available for the

dete~nination

of SGO-T

were slow, complicated and unreliable. 'l'he earlier methods for
determining the transamination reaotions may be divided into two
main types: Those whioh utilize either specifio chemical or
enzymatic decarboxylation of one of the products /lnd subsequent
manometr1c measurement of the carbon dioxide evolved and those
utilizing the high ultraviolet absorption of oxalacetate at wave
length 280 millimicrons to follow the reaction as oxalacetate is
produced or consumod. The high bicarbonate content or blood together with the low transaminase activity makes a method depending on carbon dioxide evolution difficult to apply to serum. Low
transaminase and high protein oontent together with the known
instability of oxalacetate makes the speotrophotometrio assay
difficult to apply to serum also. Ultimately a ohromatographic
method was devised for the determination ot SGO-T which, though
slow I was

l'

}liable (27). 'I'his method was the forerunner of the

currently popular spectrophotometrio method.
In the chromatographic method (1) (6), the substrates,
l-aspartate s.nd alpha-ketoglutarate J are inoubated in phosphate
burter (48) with a source of GO-'l' and the rate of production of

l-glutamate 1s taken as the measure of transaminase activity.
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After the incubation, the proteins are precipitated and removed
from the supernatant. Aliquots of the supernatant are then chromatographed by the desoending method for eir:)lteen hours, using
phenol saturated with water as the solvent and water saturated
with phenol to saturate the atmosphere ot the tank. 'l'he position
of the glutamate can be located by spraying the paper with ninhydrin. The areas of paper correapoading to glutamate are out
out and the amino acid eluted tram the paper, after which ita
concent~ation

is quantitatively determined by a colorimetric

procedure using ninhydrin as the reagent (6l).This procedure has
the disadvantage of being time-oonsuming, taking as much as two
days to complete an analysis.
A

spectrophotometric method has now been devised (26)

(4) for the determination ot SGO-T in which the transamination
reactlon i8 coupled to the reductlon of oxalacetate to malate by.
reduced dlphosphopyridlne nucleotide (DPNH) in the presence of
excess lnnlic dehydrogenase (59). 'l'he oxidation of DPNH, and
therefore the transamination reaction, 1s followed by Measuring
the decrease in light absorption at wave length 340 millimicrons,

at which the reduced pyridine nuoleotldes have an absorption
peak (46).
In this procedure, the serum sample 1s incubated in a
pH rl.4 phosphate burfer solution I'll th I-aspartate, reduced Coenzyme I and pur1fied mallc dehydrogenase. The blank contains all
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of the 11sted reactants except the DPNH. Atter

Ii

suitable inou-

bation period, alpha-ketoglutarate is added to the incubated solution. The optical densIty at wave length 340 millimiorons is
tollowed and the rate of decrease ot optical density taken as a
measure of the transaminase activity ot the serum. The activity
1s expressed as units per milliliter of serum per minute. One
unit equals a. decrease in optical density of 0.001 units per
milliliter per minute at 25°C. (26).
Serum glutamic oxnlaoetic transaminase is most easily
and acourately measured by the spectrophotometric procedure but
the techn1cs desoribed require enzymatio reaeents and speoial
equipment that are not generally available in the average clinical laboratory of a hospital or In a physician's of rice. A simple
colorimetrio procedure for the assay of GO-T 1n animal tissues
was desor1bed by Tonhazy and eo-workers (60) which was based on a
modificatIon of the Frledemann-Hnugen method (20) for the determination of keto acids in blood and urine. 'l'b1s technic for
assaying the activity of SOO-T is based on the transamination of
l-aspartate and

alpha-ketogluta~ate

to give oxalaoetate and 1-

glutamate. The oxnlaoetate formed is oonverted to pyruvate by
aniline citrate. The pyruvate then reacts with dinitrophenylhydrazine to form pyruvate-dlnitropheny1hydrazone. and thIs 1s
then extracted with toluene. V;hen the toluene solution of pyruvate-din1trophenylhydrazone is treated with strong alkali, a
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eolored compound forms, and this may be measured in a colorimeter at 490 millimicrons. The intensity of the color is proportional to the amount at' p'yruvate which in turn reflects the
level of SGO-T activity (9) (62). One unit of SGO-T is defined
as the amount of actIvity in 1.0 millIliter ot serum that results
in the formation of ohromogenic material equivalent to one miorogram of pyruvate under conditions of the test (20 minutes at 26°0.
One unit colorimetrically is roughly equivalent to approximately
one unit ot'

SGO ....T

when measured spectrophotom.etricall,.

(9).

'I'he

spectrophotometric technic is the most aocurate and rapid procedure yet devised t'or the determination of SGO-T actiVity, however (35) •
.No

change in transaminase activity with time has been

noted in serum samples stored at room temperature for tour days
(27) (34) (57) or tor periods of from one hour to two weeks in

the refrigerator at O-SoC. (27) (33). The transaminase aotivity
Q.t 370 0. is approximately double that at 25°C. (13). Its acti vi ty
was not ohanged by freezing or lyophIlIzatIon ot the serum (27).

No ohange in actIvity was noted In serum subjeoted to saoe. ~or
25 mlnutes (27). ~e~a heated to 100°C. for 10 minutes were found

to have Q deorease in aotivity to 10 per oent of the original
transaminase aotivity. The oonoentration of GO-T 18 the same in
nerum and plasma but it is as muah as ten times greater In
hemolyzed samples (27) (33).

6

Relation of SGO-T Levels to Mlocardial

.t'tec.ro~

Clinical and laboratory st\ldles performed on human
subjeots have shown that the serum level of

GO-'J'

rises signifi-

cantly .following acute myooardial infarction (34). However, in
order to determine the relationsh1p, if any, between

Rerltm

trans-

aminase levels and the amount of infarcted musole in clinioal
oases, oareful pathological studies will have to be made on
autopsy material over a span of mAny years. Therefore attempts
to determine this relationship in experimental animals have been
made (2).
By utilizing the method of Agrees (3), graded experi~ental

infarction was produced in nembutal anesthetized dogs by

inJeoting plastic miorospheres into the ooronary ostia. Serial
blood samples were taken for SGO-T determination and at autopsy
serial sections ot the heart were made at approximately 1 cm.
intervals through the left ventricles and septum. The amount of
infarction was estimated in terms of per cent

or

total myocardium

after gross study of the epicardial and endocardial surfaces and
of the serial sections (2). In all caaes the SGO-T levels rose
sharply atter myocardial infarction. with rises as great as 20 to
30 times that o!'the oontrol leyels. The peak transaminase level
occur» between 9 and 23 hours post injury with a decline atter
this point. It was also found that a relatively linear correlation
existed between the peak SGO-T levels and the amount of myocardial
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Ini'arction as esti!;1atact nt

antops~!

nnd also that in.fa!'otlon of

as little ns 10 per cent, and possibly less, of the totnl myoc(lI'dium. 1s assooiated '111 th signIficant risen in SGO-'I' 11'3'17e15 (2).
01n08 this procedure subJeoted the dogs to prolonged
anesthesi~,

and possibly secondary 11ver 1amage, the method

developed by LeRoy and associates (36) for inducing myooardial
Int'aretion experimentally was usod in order to exolude SGO-T

elovation due to injury to hepatic, renal or other transaminase
rich sources. In this procedure, a left lateral chest

inci~ion

was made, tho fourth rib resected, and nooses of braided sIlk
loosely placed aro\Uld chosen branohes of coronary arteries. Tho
ends of the ties were then

broue~t

out through stab

w~xnds

1n

the ohest at riGht angles to the artory and buried. suboutaneously
and the dogs were f:l.llowed to recover

fl~O!l

the oporation.

'l'h~l

ndvani;aCo ot this method 1s that the M"."ocar(lial lnrnrotlon can
bo 'prOChlC$d rtt any tittle subseq".lent to tho operation when the
SG(,-Ir eleVAtion resulting trOt'l injury to skeletal muscle during
th~

operation has rl"lturned to normal limits. In this 1,''fa:; t tho

a.ltl~rlltl()n

of SaO-T

oon~ontra.tlon

due to surr,ory is separated

f,..om that duo to coronary ligation. At the jeslred time, the
appJ'oprlate ties 'I,vera dra'U'/n tight. occludIng tho ooronary Rrt~rlas,

anri ser1al venous hloorl smrmles nnd eleotrooardlop,r-a.ms

were ohtitined. AgHln thf)re was

ob8er~/ed

an 1nOr99,Se in snO-T

aotivity within six hours follOWing ligation and both the degree

8
~lnd

duration of enzyme abnormality ap-pearen to be proportionAl

to the size of the infarct as deterrnined at autopsy. It was also
fotmd that the OO-T uctl'Tlty in infarcted

~j.uscle

per cent of that of nor!:'lal heart muscle (35) and
a.ct1 vi ty in 1n£a.rctGd mu.sala dim.1nish"s

ls only 2-10
~h9.t

the aO-T

proP01~tionntel:r t,:>

tha

n.:.:;e of the Inf'urct (51). ':'hi::; atron?;l:r SUE~gests that the :nechan-

1sm. of elavation of SUO-'}' activity is simply one of release of
the enzyme into the blood str98Jn following death or increase in

oellular membrane permeability.
It was also found that myocardia.1 ischemia of' 45 minutes duration did not result in increased SGO-IJ' activity. 'l'hls

1s analoeous to the usual absenoe of inoreased levels followin 6
angina pector1s and coronary insuff1c1enoy 1n :nan assooiated
\v1 th revers1ble S-'1' and T-wRve ehnnses on the EKf1.
SOO-'1' has also been found to be elevated when myocard-

lel necrosis was produced tn rabbits by the intravenous injectIon
of papain (51) (55). Although it shows 3n u.nusual specificity for
c3rdlR.c rrru.3cle, the p08s1'o11 tty of the effect of !)apa,ln u.pon

other- tr'lnsa"!1inase rich tissues cannot be ex.cluded.

It has b·.3en shown that
wh.f'm

Introduc·:~d

&.

filter:lble Virus, Virus III.

into tho ani::1.'1.1 body by the peripheral route

001;.1:1 sp~clrica.l1y

i::-d'ect the he,'l.rt ftnd pro·inc') anatO'!'1'iioal les1on!

and f'tmctlonnl derlllnr6lnelnt (53) (54). It was frn.md upon olosely

following the SC'J-T in animals s'.lbjected to intratastlcular it1-
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jeotion ot

Vl~.

III that every animal with a demonstrable myo-

oarditi. with associated muscle necroala bad a diagnostioally
significant ris. in SOO-T. Perioardial and endocardial l ••lona,
de.pIte their aeverity, produoed no change in the SGO-T levela.
indicating that the elevation ot transamina.e 18 the result ot
mu.cle injury rather than the viral Inflammatory reactIon (54).
The re.ult.

ot experiment. by NJdiok and a880clate.

(49) a180 ahow tbat tbe SGO-T aotivity waa within normal It.1ta
1n experI.ental perioax-ditl. Induced with _gneslum 81l1cat. unle.a Bubepicard1al necrosis was found at autopsy and that the
SGO-T activity remained w1thin normal l1mita 1n 9 of 11 patient.
wlth aoute pericardit1s of

v~iou.

etiologie •• In the two re-

mai.ning patient. brier and 1nsignifioant rl.e. (maximum of 56

un1t.) ocoured ('9).
In 64 patient. who were stud1ed while in vax-lous
.tag•• ot rheumatic rever, normal values were round in all oa •••
1n wbioh there waa no clinical evidenoe ot aotlve cardiao in-

volve.ent (50). Although

tre~uent17

high, the 1••• le ot 500·'1'

.ere not oons1stently elevate4 in patlents wlth aoti•• oarditis
and did not tollow the c11nlcal cours. ot the dise.s. clo••1y.
'!'he SGO-T test has proved to have great value in the
diagnosis and prognosia of myocardial Infarotion. ,any d1fterent
worker. have reported independently on the .tteots ot myocardial
neorosi. on SGO-T l.vela. LaDu. and a.soolates (33) report elev-
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attons ot SGO-T of trom 70 to 600 units within 12 hours· to six
days post injury 1n 75 patlants studIed. Denny and hls group (17)
found only three talae negatiye results when the te.t was performed on 95 pat1ents with myocardial intarction. Steinberg (58)
notes elevated 1eve18 1n over 90 per cent of myocard1al necrosls
studied.
Determinations ot SGO-T .ere aade by Kattus and coworkers (SS) on 111 patients in whIch the d1agnosis of myooardlal tntaNtton oould be established on clinical evidence and
electrocardiograms. All of the •• patient. had elevationa ot SOO-T,
provide. the .erial level. were obtained during the tirst three

to six day. follOWing on••t ot pain. The value. rise rapldl, to
a peak that 18 usually reached between 24 and 48 hours atter the
onset of pain. There 1s then a gradual tall over the succeeding
3 or , day. to normal le.ela. The higher the enay.aatio actIvity,

the longer the elevations perslat (33).
cardlal Intarctlon

.~ud1ed

or

37 fatal ca •• a ot myo-

by Kattus, 11 were uncomplicated by

other factor •• All but one or the.e had peak levels of SaO-!
higher than 350 unit. wlth a range of 357 to 6,567 units. Levels
ot saO-T oYer 350 units •• em to

c~'1

a grave prognosis. Chinaley

(lS) repvta that of 117 dlagnos.d lnta:rctions, only one ca.e

tailed to develop a high value when speCimens were taken at proper
Intenala.

ae

alao obtained evidence which suggests that the

appearance ot v.r7 high SGO-T levels may

be

a poor prognostic

11
sIgn. CbInaky alIa found normal or borderlIne levels (41 to 51
unital tor ea.e. with the angInal syndrome, acute pulmonary
edema 1n whom aoute myocardial In1'arotlon was not the precIpitating caua.,

ol~onic

congestive heart failure due to arteriolcler-

otio cardiac disea ••• and perioarditis •.
Goldner (23) and literrl1 (41) repo:rt high levels in
10 and 9 casea, respect1vely, 1n whom the diagnosis myocardIal
intarotion was definitely establIshed by 011n10al testa or autopsy
In most CA.es the levela begin to r1a. 6 to 12 hours after ooset,
reaoh the peak in 24 to 36 hours and deollne to normal

by

the

fIfth or slxth day. (29).

At the

or

~e.ent

time, when oonfronted with the probleDl

cheat pain that 18 oonsldered to be oardiac in origin, the

physio1an regards the eleotrocardIogram aa the tlnal test in

deo1ding 11' acute myocard1al in.faretion haa ocourred. However,
early EKG'a may not show evidenoe of recent myocard1al injury o.r
alae a prevlou8 myooardial Infarct may leave residual electrocardlor,raphle Boara that will neutralize wUUlges charaoterIst1c
of injury ourrent. Another well-establIshed dlffioulty in the

eleotrocardiograph1c interpretation of recent myocardial Infarot10n 18 1ta dIagnosis 1n the presence ot left bundle-branoh block

(LEBa). Normally, the Interventricular septum Is stimulated from
lett to r1ght, but In the pre.ence ot LBDB the rlght alde ot the
septum 18 aotivated f1rst and characteristic injury current 18
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loat whore IJ.H.m oocurs w1 th recent myooardial Infarotion (32).

Kraus. bas u.ed the SGO-T method to clarIfy the diagnosis of
recent myocardial infarotIon In the presence of left bundlebranch block.
HomoGenized hea,rt muscle of dogs oontains approximately
350,000 unIts of CfO-T per gram of homogenIzed tissue (33). It
all of the enz,me present were released into the oirculation ot
a 30 kilogram dog, the level in 1 milliliter of serum would be
approxImately 400 unIts. That thla Is the mechanism by wh1ch
SGO-T Is elevated following myocardIal infarotion 1s suggested
by the fact that sampl •• of intarcted muscle (cardiac) may con-

tain as Uttle as 4.000 units per grUht F'urther evidence that
the enzyme 18 released trom damaged cells is provIde4 by the tact

that SGO-T ris •• precipItously and In proportion to tbe time elapsed atter death ot the mammal studied (33). It 1. of note that
sample. trom the Jugular vein remain conaiatently low around 40
units post death wbile sample. drawn trom the 8uperior vena cava
at the same time may contain as muoh a8 280,000 unIta, the right
ventricle 160,000 unIts and the thoracio pool 100,000 unit ••
Since the enayme 18 hIgh 1n brain tissue. a blood brain barrier
preventing the escape of ::WO-1' trom brain tissue into the ciroulation }las been suggested (33).
The other transamination enzyme of ourrent clinical
interest, SeI"Wa Glutamio PyruvIc Transaminase (SGP-T) J has not
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been found to be particularly valuable 1n the diagnoais ot myocardial d1s•• s.s. The level ot SGP.T 1s altered only 1t there la
extenaive necroaia ot the myocardium. Thus, there 1s usually an
increaae in SGP-T levels only when the peak level ot saO-T 1s
more than 100-150 units. Thi. 18 probably accounted tor, 1n part,
by

the tact that the GP-T aotlvity is low 1n heart muscle as

compared to the high act1vity of GO-T 1n cardiac ti ••U8 (6a) (61).
The height and duration ot elevated SGO-T activity i .

thus .een to be roughly proportional to the extent ot myocardial
necroals. Thi. determination then, haa partioular aignl.ficance
in decid1ng whether acute heart musele cell damage haa occurred
when chea' pain, sugge.tive ot acute 810cardial infarction,
appears and 1 ••••001ated with equivooal electrocardiographic
ohange. and other indefinite laboratory finding •• Under the.e
c1roumatano •• , it the analysi. is done with proper preoaution.,
many pat1ents who have a normal saO-if le.el may be apared ....k.

of iova1141 .. or unnece.aary anticoagulant therapy_ Converaely,
1n this group of patients, acute damage ot heart muscle may be
pre.WIled to be ppeaent it" there is an elevation ot 500-'1' ln the
absence of known actlve liver 41sea •• (35).
Ilnce publonary i.n.fa.rctlon 1. often a oomplioat1ng
faotor ln the dlagnosi. ot an acute myocardial infarct, an ex-

perimental atudy has been carr1ed out by Agr•• s et a1 (1) to
determ1ne whether or not acute pulmonary Intarctlon per •• p,.-o-
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due.. signitlcant elevations ot serum transaminase levela. There
appeared. however, to be no correlatIon between amount of pulmonary Int8.l"ctlon and Increaaea In SGO ..T levels. Furthermore, min-

Imal myocardial infarction ot the order of 5 per cent wa. a ••ociated with greater transamInase rIa •• than found with pulmonary
intarotion per •• ot the order 01" 45 per cent. Thus it was concluded that thi. stUdy ot"fex-ed no evidence that acute experimental pulmonary Infarction Is a ••oclated with _ signIficantly
elevated serum transamina.. level.

Relation ot" 800-1' Levels to Llvep.Cell Damage
The relatively high GO-T actIvIty in lIver t1ssue sugse.ted that liver cell injury might result In the relea.e ot tbi.

enz,.. into the clrculat10n comparable with that already reported
follOWing aoute m1Oc&Pd1al Infarction. None of the lIver function
te.t. pre ••ntly available provIdes a useful index of the degree

ot

l1ve~

cell injury

o~

d••truotion. Molander and co-workers (45)

determined the ette.t of Intubation ot carbon

t.trachlo~id.

on

the SGO-T level in tbe whIte rat. The actIvity varied. .from a mean
01' 230

unit. in the control group to a mean ot 2,728 units In a

group ot animals reeeiving a total do •• ot 1.2 milliliters ot
carbon tetraohloride during 4 to 6 intubation •• With inoreasing
degr.e. ot hepatocellu1a:r damage produoed by gastrl0 intubatIon
of oarbon tetraohlorIde, a.s determined by' both gross and

miO:l'O-

800plc studte., hIgher ••rum

noted.

t~an.am1na..

actlvltl ••

a~e
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The height and duration ot 1ncreased SGO-T aotlvlty was proportIonal to the amount ot oarbon tetrachloride adminIstered and as

well as to the severIty or liver-cell damage (45). Neither .erum
cholinesteraae nor alkaline phosPhatase seemed to have the same
degree of sensItIVity that the SGO-T activIty posses.es In retlectlng hepatocellular Injury. Marked aminopherase (transaminase)
elevations were a180 seen in two patients who were accidentally

expo.ed to carbon tetrachloride rum•• two day8 before hospitalisation (64). The level a were 27,800 and 12,000 units, respectIVely, 48 hours atter exposure and showed a rapId return to normal within aeven day••

The transaminase actIvity bas also been followed in a
patIent receiving pyrazinamide treatment tor tuberouloais. This
patIent developed elevation ot actIvity 3 weeks berol'"Et he developed ollnlcal or other laboratory evidenoe of toXic bepatitis.
When the drug was withdrawn the 3GO-T activity returned to normal.
The fact that increaled act1vity has been round to precede the
development

or

Jaundice resultIng from pyrazinAmide and alao

ohlorpromazine auggeats that transaminase aotivity may be used aa
a tool to anticipate and thereby prevent toxic hepatitis in
patients who are receiving potentially hepatotoxio drugs (64).
In any dlsturbanoe ot 11v81" function, whether due to
aoute infeotion or to chronic liver disease, where significant
al'"ea8 ot hepatic cella undergo necrosi8, it haa been found that
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elevationa ot SOO-'1' may be expected. Measurement of SG·O ...T act ...
ivlty during the acute phase ot hepatItis, whatever ita cause,
usually permit. dIfferentiation of jaundIce due to this cause
from that due to oirrhosi8, extrahepatic obstruction of the biliary ducts, lIver metastases and h&mo118ia (64). In oirrhosis of
the llver, 8GO-T varies trom normal to 300 units unless oomplicating hepatitis Is also present. In extrahepatic biliary obstructIve Jaundice, the rise is in an inorement of approximately
200 un1ts. In proved lIver metastases, the level 1s generally
fram 80 to 300 un1ts. Wroblewski (64), on the other hand, found
that in infectIous hepatItis, the levels ranged trom 350 to 1,000
units and in homologous

se~~

hepatItis the levels vnr1ed fram

500 to 2,500 unite. Molander (44) report. SGO-T levels In patients

with Infectious hepatitis ranging frorJ 540 to 1.890 units and in
patients wIth homologous serum hepatitis ranging from 525 to

3.600 un1t ••

Fr1end et a1 (21) have reported their observations
the eftect ot Viral hepatitis on SGO-T activity in mice.
ob.e~ved

wise

or

~~ey

that the liver-eell 1njury due to virus hepatItis like-

~••ults

In an Increase in SGO-T aotlvity which 18 roughly

proportional to the amount of. inooulum given, to the amount ot

virus In the blood and to the extent ot histologioal neorosis of
the lIver. Oe Ritls (18) reports rises In both SGO-T and SGP-T
levels during viral hepatItis but the 1'1.86 1n SGP-T Is larger than

1'1
the SGO-T and tho x-atl0 of 500-'1" to SOP., 1s deer..."8d.

The aminopberase act1vity appears to oorrelate .011
with the ollnloal atatus. Peak levela

or

am!nopheraae are uaually

to\.1lld when the pati8Dt 1s slok••t ...a aan1teated by lethal'gy.

rever, anorexia. Daua_ and vom1t1ns (64). Conver-••ly. the pa1tlont. beoome more alo" and atebril. and bave htUPDot appoti t.
abortly .,Zt.- the usuall,. preelpit10U,s tall

or

$GO-!

occur,,_ The

soo-'t actlvlty does not altaI' 1n the ..... dl...otlon. magnitude
time .e any

or

~. o~tly

01"

employed 11ve1" funct10n teata. There

18 no cowelation between the SGO-T aot1vlt1 and tho erythrooyte

aed1118ntat,1on Nte, wh1t. blood con oount. t8llp8ratur8 or 0HaCtlYO protetn (85). 'l'be other toet. or 11"8" tunot1on uwal1y

are abnormal tor day.

O)!I

.o.le. after tile t:raneaatnan aots.vi

t,.

baa retwmedto n01"llal (&6).
From the ob.or¥atlon or 40 patl.n'..l tb various aoute

hepatl0 dl........ l.t appears that ante

b.patS.~l.

18 alao •••00-

iatri with a ria. 1n ooP-1' acti"lty of' f'l-<.Ia 2 to 1.000 t1._ Ule
nol'JDal (61) (68). The peale ria. 4urlng the C01.1He ot cUn1cal

hepatitis 18 roughly proportional to tn••••er1t7 ot tbe di •••••
proo•••• In aout. hepatiti8. the SGPwT aotivity 1. peater thaD

that of' 8GO-1'. Consequently. the ratio of SGO-T aotivity to SOP..'l'
activity (SGO-1'/SGP-T) taU. fitOlll the normal uan yalue o~ 1.3

to 0.64 (18) (19).

The .... a1m1larlty ot SGP-T and SGO-T concentration
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was .een ln pat1ents wlth extrahepatic biliary ooatructtve jaund1ee. Cirrhosis of the liver 1. a ••oolated wlth inoreased SGO-T
and SGP.T aotlvlty in whioh the SGO-T aotlvity 1. usually greater
than the SGP-T actlvlty. Infiltratlon or the llver by leukem1a or

lymphomatous di ••••• may alter the SGO-T but haa not been .een to
cau•• elevatlon ot the SGP-T aotivity above tbe normal range (67).
It appear. that

sao-'lt aotlvlty

1. a more aenalti"e n-

flection or ohronlc hepatic di..... and that SGP-T ls more readi-

ly el.".t.« byaoute hepatltis (67) (68). By the simultaneous
measurement of 800-1' and SGP-T lt may be po.alble to d1fferentlat.
acute from ohronlc ltv.p-o.ll damage. SOP.If, unllke SGO-T I has
the added advantage of USUAlly not belng appreclably elevated by
aoute myooardial infarction except in the presenoe of' extensive
myooardial neoroal ••

The pre.ence 1n hepatlc tlssue homogenate.

or

ably 1••• GP-T than GO-T sugge.ta that the r81atlvely

consider-

gr.ate~

In-

crement ot SGP-T aotlvlt7 in aoute liver diee•••• oould not be
solely due to rele••• ot the enB,me from necrotic hepatic tissue.
Variation. in the relea.e, destructlon or excretion
ena,..s or an unknown aberration

~.

or

the two

probably Important contrib-

uting meohan1 ... and b&"e yet to be clarifled (6'1).
The natural uncomplicated oourse of infectioua hepatltl

1. a.aociated with a gradual rl •• 1n SGO-T actlvity to a peak,
followed by a gradual deore••• ln .erum enz,.. aotivlty toward
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the normal range during the recovery phase. When

In~eotion.

or

other oompllcations ~oour during the oourse of hepatItIs, the
added stress tends to influenoe the hepatitis and this i. reflected 1n a aecondar,., superimposed rise in SOO-T actIvity (63).
Ambulatlon durine, recovery from Infectious hepatItis 1.
sometimes asaoolated wIth a small secondary rise h'l SGO-T acti vi

t, .

If the riae following ambulatlon 1s 50 or more unIts, return to
r8st dIscipline appears advisable, and SGO-T activity usually

resume. its return toward normal. Assooiated with the seoondary
rlse due to ambulatlon are uaually reappearance of malaIse, hep-

atic tenderness and right upper quadrant pain which also disappear
a8

the SGO-T returns to normal.

SGO-T elevat10ns above the normal range read1ly permit
the detection of acute hepatlt1s in the asymptomatic or prodromal
phase after exposure to infection (63). The SGO-T level may con-

tinue to ria. tor 50 to 60 days prior to the onset of nausea and
anorexia, during which time the other liver funotion testa may
remain normal. Th1a would sues.at that measurement of SGO-T ot
all contacts during an epidemic would permit differentiating
those indiVidual" who mny develop infectious hepatitis from. tho ••
who are to remain well.

~he

tormer group eould then be prophylac-

tically treated with immune globulin without unneeeasarl1y admin1ster1ng this material to the larger group with normal SOO-1
who are not potent1al oandidates for acute hepatit1s.
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The transaminase test bas been of uae In evaluating the
signifioanoe or alkaline phosphataae elevation (66) sinoo the
5UO-1 level 18 normal when the phosphatase 1. elevated a8

Q

ro-

tnut ot bone d1..... or bono meta.ata... but rlses when conoom-

itant alka11ne phosphatase elevatlon 1s due to liver d1seaso, Including liver ••ta.ta ••••
Hudolph (56) has reported .levations ot: sel'Utll glutamic
oxalacetio transaminase

rol~owlns

experimental infarot involving

kidney, spleen, lungs and bowel. It 18 evldent in these studl ••

that nocr0818 ot many types ot tIssue. results 1n elevation of
SGoJr. Aa the amount of tissue rendered necrotic is reduoed, the

amount of en.,.. appearing in the peripheral oirou.lation is com-

mensurately l •••• n.d and may £&11 within the normal range. This
ls tru.e a.lso of ischema. ot ahort duration.

In

anoth.~

.et of experiments D7 Milch and Albaum (43),

rabbit. woro expos.d to A-irradiation in dOBages of 500, 150 Qnd
1,000 r. A significant increa.e in SGO-T could be identified at

6 hours in the group subjected to 500 r and as early as 3 hours
post 1rradiation 1n the 750 and 1,000 r groups. No relation waa
found. between S60-'1' elevation and surv! val time so 1 t would. seem
that survival depends, in the main, on the animal's ability to

overcome and repair the insult.
In aumm.ary, the determination 01' SGO-T aotivity seems

to have great pot.ntlal value in the eatimation of the extent

or
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tissue necrosis in myocardIal infarction and acute and chronio
hepatitl. since the peak levels

or

800-T elevatIon approxim.ate

the tissue damage. It is a useful tool in diagnosing myocardial
Inta~~tIon

In the presence of chest paIn which may be due to

chronic oongestive cardiac tailure, angIna peotoris, aoute pulmonary infarction at cetol'a.. Levels of SGO ....T over 350 units
aooompanying a myocardial infarction carry a grave prognosis.
'l'he SGO-'r teat 1s a useful tool for distinguIablnt,; Jaundice due
to hepatiti8 from that due to cirrho81a, extrahepatIc obstruction
of the biliary duots. liver metastases and hemolysis. It may also
be a means ot predetermining which ind1viduals exposed to hepatit1s will be afflicted with the disease and also a tool to anticipate and thereby prevent toxic hepatitis in patients who

a~.

re-

cel'11ng potentially hepatotoxic drugs.
Serum glutamic oxalacetlc transaminase elevations above

the normal level have not been .e.n in patIents with Inrectloua.

neoplast1c. metabolic or degenerative diseaaes in which acute or
chron10 de.truction ot heart, skeletal MUacle.

live~

or one ot

the other transaminase rich tissues could be excluded.

The enzyme glut ami 0 oulao.tic trtUl.$amlnaae 1s

II.

nor-

mal oomponent ot the aerum. proteins _ but :n..s been found to be

oons1derably elevated In certain
primarIly cardiae muscle

patholo~lcal

tissue. The

~ld 1lve~

state. involvIng
~ec.nt develo~t

ot a 8impllf1ed, accurate and tairly rapid speotrophotometrio (26)
method for the ,determination 01.' the enz,.. In serum has led to
enhanoed intereat In the clinIcal implications ot increased

le"els ot the

8n~yme

&hove the nqttmal. The ourrent work being

reported In the literature deal.

~lmaPl1~

wIth attempts to

correlate the e1o.,..ted SCO-T l.vele with degroe of: tissue damage
due to aoute myocardial infarotion

01"

to 11v.,,-0811 injury

cauaed by homolo£oua ••J'UllIl, infecttous or toxio hepatItis, otrrhosla

01"

canoer. In spite or the clInIcal interest 1n serum

Glutamio oxalacetia

t~ansam1na8e,

little tUlldamenta1 blochemioal

work haa been 1"epoJ'ted on this serum protein to date.

Tb1s reaeareh deals with an attempt to pre.ent a fur-

ther bloohemical oharacterizatIon ot the enayme tram the point
of vIe. ot it. 91eotrophoretle m1gntlon pattern, 1 ta t!'&otlonal

precipitation properties and the nature or the linkage between
the enzyme and ita

oo.n~Jm.,

pyridoxal phosphate.

In determln1nc the eleotropboretio pattern or 8erum
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glutardo oxalaoetic transaminase, the

.8l!'Ullt

proteIns of·the

whIte rat "eN ••paNted lonographlcally into disoz-ete banda on
tiltep paper atr1p. usIng the Prec1s1on type tonograph (39).
The bands were then out from the strIp and the proteln fract10ns
eluted f'rom the filter paper with a phosphat. butfer solution.
Each of' the eluted sample. was then analy••d tor transaminase
act1v1ty by the speotrophotometr10 prooedure d.8Cl'ibed by Karmen

(26).
It haa been sugge.ted that the linkage between the
enz,.., glutamic oxalacet1c transaminase, and P'11'idoxal phosphate

1. ot a non-1on1c nature due to the un1versally exper1enoed
diffIculty 1n resolving the enzyme into apoenzyme and co-enzyme
and to the requirement for relat1vely prolonged preincubation

periods between co-enlyme and apoenz,.. tor activat10n ot the
vitamin Be-enzyme (42). In this roe ••arch an attempt was made to
determine it the protein band containing the maxImal transaminase
activity was tully saturated with pyridoxal phosphate and it the
position of maximal aotlvity on the paper strip would be altered
by

the addition ot the co-enzyme to the spectrophotometrio reac-

tion mixture.
In the traotional preoipitation ot the

.e~

prote1n.,

to determine w1th whICh traction the transamina.e aotlvlty was
assoclated. the protelns .ere removed trom solution by the process known aa "saltlng out". The albumin and globulin traction.

wore separated by salting out wlth ammoniw.1 aulfQt. and· the

fraction. were tested tor transaminase aotivity by the spectrophotOl1et~lc

method. of Karmen (26).

CHAPTER III

THE :6LECTfWPUOhE1'IC

MIOHA~J.lI<i:i

OXALt1.GETIC

PA'l'TERN OF SEH!J!t1 GLUTAiUC

~:IUU1SAMINA~S

I'rom Chapter I. it has been seen that the concentratIon
or serum f;lutamio oxalaeet1c transaminase correlates well with
the degree of' myocar<.l1nl infarction. Also, in persons with coro-

nary atheroacleros1.s. or with d.t.eases predisposing to a.thero-

solex-os18 (diabetes, nephros1s), there 1s a tendenoy to the reduct10n ot" albUI'n1n and alphfl lipoprotein and a relative and ab-

solute increase 1n beta lipoprotein (30). In a report made b,. the
Comm1 ttee on Lip1d and Lipoprotein l101'll.nelature

or

the Ameri-

oan Soeloty for the Study of Atherosclerosis (8), it was suggost-

ed that the

te~8

alpha and beta

11po~ot.In8

be restrioted to

lipoproteins w1th electrophorotic mobilIt1es of the alpha and
beta globuUns of the eel'Um, respectIvely. Slnoe there Is an

increa.e 1n the concentrat1on of the

p~otein,

~10-T.

1n Myocard-

lal infarotion and an 1nOre&8& in the beta lipoprotein fraction

or

the ser-am lipoproteins in coronary atherQsolerosis, it was

thought that the SGO-T might 1n some way be associated with the

b6tn globulin fraction ot the

se~

proteins. In order to study

the electrophoretie pattern of SGO-T then, the electrophoretio
separation of the serum proteins in a paper stabilized medium
was selected

a8

the tool to be used sinoe it has became a widely

26

utilized and useful aoans of studyine these

p~otoins

in both

normal and pathologioal states.

Qholce ot

SamRl~

Slnce, 1n eleatrophoretic separations in a paper

stabIlIzed medium. the sample size 1s great1l limited, particularly if pap.r strips are used, samples contain1ng relatively
high concentrations o£

~.

enzyme are desired. It has bean aeen

that the enz,.. 1s in greateat conoentration in the serum during
pathologies involving ntlarosia of transaminase-rich t1ssues. These
serum. samples .ere not readily available. however, and sinc.
normal

h.urJan

serum 18 rela:tively low in transaminase aotlvity.

with a range of 8 to 40 units and a mean of 22.1 units (standard
deviation of 6.8) (33) (45), It was neoe.aary to obtain samp16.
from another sourc •• Fortunatel" for

exper1~.ntal

purposes, tne

SGO-'.r a.ctivit,. bas been found to be spec18. speoific and in rat.

the normal varies from. 1'/0 to 350 unit. (45). while in th.. :mouse
it varies between 50 and 125 unite (21). Oonsequently, it was
decided to U8. white rata as the source ot serum samples sinoo
the,. .... r. readily available and eaaily . .1ntained. 'l'he rata u ••4

as a.rum donora

.e1'8

maintained on PurIna }o'ox Chow and no regard

was taken tor the fasting state prlor to taking the blood sample ••
Method of ~am.Phin&

The ooncentration of glutamic oxalacetic transaminase
1& the same in .erum and plasma. but 1s up to ten t1r.185

!:~.&ter
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in samples containing hemolyzed red blood cells (27) (33). The
s~~ples

used In this Investisat10n ware serum samples since they

were more easily obtained than plasma. Blood samples (3
in 8ize) were obtained

by

m1ll1l1te~~

heart p-unctures on ether anesthetized

white rats, using a Gold SeQl. 5 co. syringe (i>i7373) and a 1 inch

Yale stainless ateel needle (No. 13-1> 20). The samples were allowed
to olot at room temperature for approximately five minutes and
then were oentrifuged for ten minutes at approximately 6500 r.p.m.
1n the International Clinical Centrlruge (No. 24859). The clear
supernatant serum was then decanted and hemolyzed samples were
discarded In order to keep the conditions as constant as possible.
The serum samples were tightly stoppered and. stored In the refrigerator at SoC. unt1l application to the paper strips. The enzy.me
1$ quite stable and no change haa been noted in transaminase activity in aerum sruuples stored at room temperature tor as m.uch as
four days (27) (34) (57) or for periods of from one hour til two

weeKS in the refrigerator at O_SoC. (27) (33). l~e unexpected
stability ot this enzyme was evident from observations that were
.made by Sobel (57) on 2 groups ot samples, each group conSisting

or

2 samples ot normal sera and one sample ot serum with an In-

creased level of transaminase. One group was kept at roam temperature (apprOXimately 25°C.) tor 19 days and, although there was
a oonspicuous growth of bacteria, no significant decreaaG was ob-

served in tne transaminase activity. The other group ot 3 sample.
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was incubated at 37°<.;. 'rhere was a decrease or 30 per cent ot the

activity in one sample within 3 days. whereas the other two had a
loss of only 7 per cent ot the activity in 9 day••

l~e

activity

of transaminase at 37°0. i8 approximately doubled that at 25°C.
(25). The transaminase aotivity is not changed by freesing or lyo-

philization ot the aerwa (27). lio change in aotivity was noted 1n
aera subJeoted to 56 0 e. tor 26 minute. (27). Sera heated to 100°0.

for ten minutes were found to have a deorea•• in activity to ten
per cent ot the original activity (27). Although the transaminase
aotivity bas heen round to be remarkably stable, it was round

that the ionograph1c patterna were increasingly more indistinct
a8 the seru:m aged. The mobllitie. decreased and the bands ....re

cons1derably less d1stinct slnoe there was more amearing 1n the

samples stored at 5°C. tor more than tlve days. Consequently,
serum samples more than three days old ....re not used for the

electrophoret1c separat1ons.
Var10us sample alzes were run electrophuret1cally to
asoertain the largest volume of serum that could be separated
and stll1 giva clearly defined bands. The sample sises tested

were 1, 2. 5 and 10 micro11ters. While the 2 microliter sample
would have been the choice had soannlng ot the lonograms been
nece.sary, the 5 microliter sample gave very distinct patte1"ns

upon v1sual observation. Samples larger than 5 microliters gave
very 1ndistinct patterns due to smearing, probably caused

by

the
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1arb6 amount
serum against

01'

albumins which were present. Dial:;sis ot the

butl~er

did not seem. to be necesaar:.r since the pro-

tein bands were already 018&1'11 defined with the sample size used.
'l'he IQn0.sa:aPhj.c SeRaratloa of £40 Strum. Proteins
The apparatus used in the sepnrt.ttion of the serum proteins

'flUS

the 1onograph ll'ls.nu1"actured by Precision Scientific Com-

pany. Chicago, Illinois. Tuo PI'ototype of this apparatus and the

experim.ental technique employed in its operation have been described in detail by MaVoIlald. at al (37) (3a) (39). The temperature

ot the system. wa.s t1aintained constant at :25°(;. throU;?).lout all run.
by

oiroulating water trom a constant temperature bath thrOll.gh the

apparatus. The materia.l used

'UI

th.e stabIlizing medium was Whatman

No.1 filter paper (one-half inch in width) (7).

1~e

butfer syste.

used was varonal (.:iiethylbarbiturl0 a.cid and sodium dlethylbarblturate) of ionic strength 0.0'7, pH B.ag at 2SoC. and a. total con-

centration ot 0.0772 molar (Appendix). Trial runs were

rr~d~

using

veronal butfers of ionic strencths varying from 0.03 to 0.07 in an
effort to

det~rm1no

tha lowest ionic strength at which satisfaot-

ory aeparations oould be made. At the lower ionic strengths, the
separations were more rapid but there was inoreasingly greater
diffusion as the ionic strength was reduoed. The conditions out-

lined above seemed to be optimal tor the type of separations desired althOUGh the ·iJimo necessary for the separations was increas-

ed. A water saturated. hellu...'11 atmosphere was lualntained in the
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chamb~r

or

the tonograph in order to di.sipate tho electrical

energy developed in the strIps and to mln!m1ae the 10.. ot water
by evaporation (39). The method of tonography u •• d was the horizontal strip method described

e~l1er by

McDonald at a1 (39).

The strip. (31 centlmatera 1n length from bufrer to
butter) were saturated with the veronal solution prior to being
plaoed in the

lonosrap..~.

A one hour equ1Ubr-atlon time was maln-

talned under the same condItions ae the run 1tselt before the
aerum _.p18. .ere applied to the oenter of the paper strip. A

potent!al of 4.8 volts per oentlmotar was then applIed across

to.

strips oonta1n1ng the m1({;rcmt to'!! a total of 7 ho1..lrs. Hoth the
leacUns edge and the trail1nr; ed&e of the vulou. protein band•

••ra mea.ured. Under tn.

cor~tlon.

desorlbed, the names of the

protein ~ildS starting with the one furthermost f'roa the point ot
!

application and 1n the direotion

or

alphal-~l.bulln, a.lpb.a~t·'Slobulln

and hota globulin. The gut.:u!

the positive pole are albumin.

globulin t1"actlon moves toward the negative pol@ under these con..
41tlona <,f). It plasma samples had o.8n 1180d there would have been
.'tlb:rln(),en band between the bets. and gamma gloouUns (6). Tho
~.tano ••

J:lov.d by the various protein traotions are given ln

table I.
!

Arter the saven
;)01')

ho~

wero X"OtaOved from the

separation. the str1ps (7 in num-

lono~uph

and dried ut a tom:pevaturo

not exoeoding 3"oC. '111 th a aarvol Hair Dr;,"er, Yodel Br'H-25. manu-
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TABL'E I
DISTANCES

(in centimeters) HY THE SERUM

MO~'D

PROTEIN FRACTIOIS UNDl-::R Tft..E COIDITIOlIS OJ<'

T'ai~

:EXPERIYENT

.

,

Protein Fraotiona

1

2

a_pl.
a

Albumin.
Loa4100 Kd~
~ll1rig E

t(WIlbel'

"

I)

6

fl

Ave. S.D.

4.3 4.6
3.3 3.8

4.3 4.3
3.5

4.4 6.5 4.2 4.4 .t 0.14

3.0 3.8
2.5 2.6

3.0 3.0
2.6 2.4

3.8 3.1 3.0
8.6 9.6

3.'

8.7 3.6

3.4

3.5

-+ 0.18

Alph~-globulln:

LeadltlG Edge

Trailing E4ge

I.'

3.1 + 0.14
2.6

i

0.09

Alpba2-g1obul1n a

I._cling ~

TJltall1ng E
Beta

•

globuUnl

Leading Ed;e
TralUng EdS_
G_

0.9
0.3

1.0 0.9
0.4 0.4

0.9
0.8

1.0 0.9 0.9 0.9 + 0.06
O.S 0." 0.4 i 0.07

0.4

elobul1rn

*'

Leading Edge
'l'Z'a1Uns Edge

*

2.2 1.9 1.9 a.o 1.9 1.9 a.o .1 O.lS
1.3 1.4 1.4 1.2 1.6 1.3 1.3 1.3 ± 0.11

a.o

-1.4 -1.3 -1.2 -1.4 -1.2 -1.2 -1.2 -1.3 .%. 0.10
0.0

0.0 0.0

0.0 0.0

0.0

0.0 0.0

-

+ 0.00

Negative sign indioate. migration toward the negative electrode
in the tonograph.

S.D •• Standard Deviation.

tactured by M1ma.r Products, Inc., Brooklyn, New

Yo~k.

One str1p

from eaoh set ot seven strips was then stained tor prote1n with
a Bram Phenol Blue solution (Appendix), the color developed by
washing the str1p 1n dilute aoet1c acid and the aold removed by
washing 1n dist1lled water. This strip was then dried in an oven

at 99 0 0. and used aa a reterence to locate the protein bands on
the other 8ix remaining str1ps. The areas corresponding to the

prote1n bands were then cut tram the str1p and atter a total at

ten runs on the 1onograph the bands .ere combined, making a total
01"

8ixt,.

bands

per prote1n traot1on. Since 5

had been applIed per paper
the

at~ip,

m1c~o11ters

this oombined sample

01"

.erum

r.p~.8.nt.d

prote1n traotion tram 300 miorol1ters 01" serum. Each of the

combined samples was then balanoed against an equal we1ght

or

the

filter paper, out tram a section 01" the filter paper strip out at
the range of tn. migrating proteina, whioh was used as the cont:rol 1n the sub.equent apectrophotometric analysis. Both the protein bands and the oontrols were then eluted. with 0.1 M. phosphate
burter ot pH 7.4 (Appendix). The eluate was d11uted to 3 milli11te:rs with the phosphate butter. The sample was now ready tor
analysis ot transaminase activity by the speotrophotometric method
described by Karmen (4) (2a).
Suctr2pholcetr,le DetemeaticD ot 'rrag8!!!!naae Act1vitZ
In the spectrophotometric •• thod, 0.5 ml. of 0.2 M. 1aspartate (Appendix), 0.1 ml. ot a buttered solution of malic de·
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hydrogenase, 0.3 mi. of a buffered solution of reduced dlphosphopyridine nuoleotlde, 1.3 ml. of the sample solution and 0.6 ml.
of 0.1 M. phosphate butter were incubated tor 30 minutes at room
temperature (appro~lmately 25°0.) in a 3 co. 81lioa absorption
cell. The referenoe cell contained the same components as the
sample cell exoept that an additional 0.3 ml. of 0.1 M. phosphate
bufter solutIon was subst1tuted tor the 0.3 ml. ot reduced Coenz,.. I. The control was run exactly as the sample. Arter the

tb1rty m1nute 1ncubation period, 0.2 ml. ot 0.1 M. alpha-ketoglutarate solut1on (Append1x) waa added to the react10n mixtures

1n the 3 ec. cuvette. and the rate ot deereaa. of opt1oal denaity
was .easured at wave length 340 mil11miorons over a thirteen
hour period on the Beckman DU Speotrophotometer, Model 2400,
Serial No. 130423, wIth a Sorenson Power Supply, tfNOBA'J.!RON" MA6501, and a Beekman Hydrogen

L~p

Power Supply, Model 2965,

Ser1al No. 118133. The rate ot decrease ot opt1cal denslty ls
taken .s a meaaure ot the transaminase aotlvity.

Auto-oxidation of the reduced dlphoaphopyrld1ne nucleot1de takes place durIne: the th1rteen hour

l"\Ul

as aeen from

the graph ot Figure I and Table V (Appendix). The solld 11ne in

Figure I repre.ents the spectrum of a solution contaIn1ng 0.3 ml.
ot reduoed Coenzyme I (approximately

o.a mil11gram per milliliter:

and 2.7 ml. of 0.1 M. phosphate butter in the cuvette•• The dottec
line represents the spectrua ot the same solution atter thirteen
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by

~~a

auto-ox1dat1on 1s compensated

the control which Is

and the

d1r~e~enoe

!'Un

~or

In the

expe~1ment

with each protein sample, hoff.ver ..

between the decrease In optIcal density of the

sample and that of the control (designated here as "actIvity
unita tt ) 1s taken as the measure of the act1vlty present in the
.samples. Thi8 .ethod 18 a modIfIed version ot the one deso-rlbed
by

Karman (4) (2S) tor the determination ot SGO-T in serum.
The reaotion was carried out at pH 7.4 as a. result ot

the finding ot maximal activ1ty tor saO-if between pH 7.0 and 8.0.
wb1ch 1s in agreement with the results of Cohen (13) and others

using pig heart

~cl.

a. the source ot the ensyme. It was con-

ducted at roam temperature ot approxImately 25°0. tor convenienoe
even though the aot1vIty 1s practlc.lly doubled at 31°0. (25).

The 30 minute Incubation perIod was ma1nta1ned due to tho r1nding
by Karmen (a6) that when

reduced Coensyme I 1s added to serum

wIthout additIon Gt substrates, the optical density of the m.1xture

deore.... tor s1x to Beven m1nutea. indicating the oxidation

or

fInite quantIty of reduced Coenzyme I. Atter this reaotion haa
stopped, completion Of the transamination sy.tam results 1n a
steady deorease in optIcal density •
.Karman found that the rate or amount of DPNH oxidation
by

serum alone 1. not ehanged by the addition of malie dehydrog-

en.... and e1ther l-aapartate or alpha-ketoglutarate (2S). The
amount oxidized. 1s not apprec1ably affected by adding more DPlm:.

a
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a .. alao round that the addit10n ot 0.2 ml. ot pota ••lu.m.p;rruvate
(4mga. per

ml.) atter th1. reaotion baa stopped, reau1ta in com-

plete oxidation ot the DPNH pre.ent at a measurable rate, demonstratIng the pre •• noe ot laot10 deh,.drogena.. 1n ael"UDl. Dialysi.

or

the serum against 0.1 M. phosphate butter reduoe. the amount

ot DPNH ox1d1.ed w1 thout ohanging the .eaaUJ'able transam1nase
acti '1'1 t1 ot the .erum, Indioati.ng a 108. ot pyruvate b,. the .el"Wl.
during the 41al,.si.. Karman has theretore suggested that the oxidation ot DPNH by .erum alone depends on the pre.ence ot pyruvate
and lactic dehydrogenase 1n the .erua. The reaotion atopa when
all the pyruvate 1. enzymatioall,. reduced to laotate by DPNH (26).
i

Omitting malic dehydrogenaa. trom otherwi •• oomplete
transaminat10n reaotion mixture. re.ulted in a variable decrea••
1n the ob.e:rved rate ot

DP~nI

oxidation. That the l'eaction •••

atl1l meaaureable waa taken a8 .uggestive evidence either tor the
pre ••noe of maUc dehydl'ogena.e in .el"UDl or tor the decarboxylation ot oxalacetate to pyruvate and subsequent DPNlI oxidatlon
by lactio dehydrogenase (26). Addltion ot more malio dehydrogenase to any ••rum transaminase a8S&1 re.ulted in no further increase 1n the measured rate of reaction, ind10ating that the
ane,.. was pre.ent 1n exc ••• in the •••al mixture.
Study or the variatIon of SGO-T aotivity with substrate
ooncentrat1on Indicated that maximal actIvIty was obtained when
the 3 milliliter reaotion mixture contained more than 50 micro-
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mol•• of I-aspartate and 5 m1oromole. of alpha-ketoglutarate. One
hundred mioromoles of l-aspartate and 20 micromole. ot alpha-ketoglutarate were used in subsequent determinations (26).
The reaotions ot both the sample. and the oontrols .ere
followed over a thirteen hour period by measuring the deorea.e in
optical densIty

a8

the reduced dlphosphopyrid1ne nuoleotide 1s

oxidized. The 41tterence between the deore.s. 1n optioal dens1ty
ot the sample and that of the oontrol was taken .s the transaminas. aotivity and d.s1gnated

a8

"aotivit,. units" 1n

l"~1gure

II. The

deorea.e 1n opt1oal density attributed to the various prote1n
tractions are likewise tabulated 1n Table II.
As

oan be seen trom jiligure II and Table II,

80me

reduot-

ion in optioal density 1. brought about by all of the traotions
teated. Thia reduotion may be due to a protein ettect on the DPNH
or to the pre ••noe ot small amount.

or

tran.amina.. in allot the

tract10ns. 'rhe enzyme .tteot i8 seen to be ooncentrated in the
are. ot

t~

alpha2-g1obul1ns .nd the a.e. 1mmed1ately tollowing

this prote1n traction. The activity in the tractIons behind the
are•• or maximal aotivity may b. due to adsorption or the en.,...
to the tl1ter paper strip durIng the prooe8S or electrophoresis.
The aott"11 t7 1n the area. preceding the alpha 2-g1obuUna 8y be
due to some ot the enzy.me being more or le.8 swept along by the
large bulk ot albumins pre••nt 1n the .erum.
Contrary to expectation, relatl"18ly little of the trans-
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TABLE II
TRANSA:4INASE ACTIVrry OF 1'1m VARIOUS SERU14 PROTEIN
F'RAGTIONS AFTER THIRTEEN HOtfRS

Decrea •• in 02tical Density
Protein }'ractionl

1

2

3

"

5

Ave.

1. Albumins

0.025 0.150 0.066 0.012 0.032

0.057

2. Albumin to Alpha l

0.025 0.056 0.048 0.014 0.011

0.031

0.030

5. AlphaS

0.119 0.187 0.081 0.151 0.037

0.115

6. Alpha a to Beta

0.194 0.072 0.086 0.348 0.092

0.158

7. Heta

0.050 0.054 0.037 0.127 0.024

0.058

9.

0.013 0.027 0.021 0.041 0.010

0.022

Q.amm.a
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amin&88 aotivity was found to be conoentrated in the beta globulin traction ot the serum proteins. Thu8, there apparently ex1ata
no correlation between the increased beta lipoprotein levels in
athero8clerosia and elevated .erum glutamio oxalaeetic transaMin.se level. in myocardial infarctions.

CHAPTER IV

COENZl'lm El"f'ECT ON TRANSAMINASE ACTIVITY OF IONOGRAPHI-

CALLY

SEPARAT~D

SERUM PROTEINS

It haa been stated that most of the amino aolda wl11
undergo the

tran~1natlon

react1on. Herbst (24) haa reported

that enzyme catalyzed transaminatton reactiona proceed only If
one . . .ber ot a transaminat1ng pair 18 a d1carboxy11c amino or
keto acid. Pyridoxal pho.phate haa been shown to act as coena1Jl1e

1n tranaaminatlon reaotions (22) (46) and OtKane and Gunaalus (52)
have determined the ooens,... saturated C\1PYe • •81s'31", Sobe". and

Peterson (40) bave found that both pyrIdoxal and pyrldo:um1ne
phosphat.s aot &8 ooenzymes tor h.art llpotranaamina •••• The ••
lnvestlgato!'s found that simultaneous m1x1ng of" P1PIdoxal ph08phat•• ensyme and substrates r ••ultea in low aotlvlty, and that

pre.inoubatlon ot ensyme and pyrldoxal phosphate was necessary
for appreoiable actlvatlon with low ooncentrations ot pyridoxal
pho8phat•• For pre-inoubation periods ot 1••• than one hour,

pyrldoxal phosphate actIvated the tran.amination reaotion significantly more than pyridoxamine pho8phate, but upon longer periods
of pre-Inoubation. equivalent aotivtty was observed with both

phosphate •• ter. at the same conoentrations. The data are conslstent with the hJPOthesi. that aotivation require. enz,meooenzyme combination <40). The requlrement for relatively prolong-
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84 pre-incubation periods between coenzyme and apoenzyme tor
activation of the various vitamin Bo enzymes sUggests the presence ot aome type ot non-ionic linkage (42). The universally
experienced difficulty in resolving the.e enzyme. into apoenzyme
and ooenzyme a180 18 consistent with the formulation of nonion1c
linkage. (42).
The mecnanism ot aotion ot these coenzymes i8 not
detinitely established, and a pure transaminase baa not yet been
isolated (46). The beat preparat10n 1& probably that of Cohen

and Cammarata (10) (11) who report that low temperature aloohol
fractionation appeared to of tel' some advantages

OVel'

the arnmoniUDl

sulfate tractionation proced\1re which yielded a p&.l"tIal11 or
completel,. :relolved product in low yield. This preparation ot
Cammarata and Cohen contained s8vera1 metala" however.

8.S

judged

by emis810n spectrography (46). However there •••m8 to be good
eVIdence (42) (46) that in transamination, the pyridoxal phos-

phate forma an intermediate Sohitt bas$ with the amino aoid. Th1.
intermediate is then

p~esumed

to decompo.e into the corresponding

keto acid and the amine tor.m ot the ooenzyme.
Snell and his assooiatea (42) (46) have found that
oerta1n matals (oupric. ferrio and aluminum ions) aotivate nonenzymatic tl'ansamination with pyridoxal phosphate. The reaction
require., in addition to the metal, the presenoe of the tree aldehyde, phenollc hydroxyl and ring nitrogen in the pyridoxal.

They augSeat that the formyl group funotions 1n \he formation of
a Sohilt bas. with tn. tm1no acid,

tn. latter intermediate being

stabilised to the nece.8u-y degree by ohelation with the catalJtlc

metal ion via the nitrogen of the resulting aaometblne linkage,
the phenolio group and probabl,. \he carboxyl

~u.p

ot the IlUI1no

actd re.idue (42).

The.. non-en.ymatlo r'fIaotlona oorre.pond .erry

010••1,.

to the ."''1JI&t10 Hactlonl 011..,.1,..84 by 'dtudn Be protetna and

1t baa been .a. . .d by Snell et a1 (42) that the latt•• prtOoeed
by a I1J111al' uobard. ... 'the

"qui....,.' or .tal

lons tw non-

enz,...tl0 traneaainatlon augg••' . that suoh tona may Uk..t •• be
....ntl&1 tor the en.,mat10 reaotions, but only limited indicatlon.

or th1.

ba•• been obta1ned to date, and It ls polalble tbat a

ponton ot the p1"Oteln ena,.. 1, ••I t oould tulflll the role p)a;ted
by . .tal lona 1ft ttut non-ena,.a.tlo r ..ot101'l. It 1I8tal Ions a •• In-

volve4 In the _ • ..,...t10 ",eaotlon. the unocoupled ooO!'dlnatlon poa1tlona ot the .....1 ohelate. tOl'ftllate4 by Snell (4a) oould be
ocoupied b:r sroup. from the Gpoen• .,... thu8 turnlah1ns a common

tl. between apoena,..,

o~n.,..

and substNte.

Many dirt_en' reaotiona ot a.mino aold. aN oatalyzed

b7

p~14oxal

Phosphat. containing enaymea. Most ot tho.e

ensymatl~

..... tton. ba.e befm dupUoated by rlOn-4tns,..tl0 model "aotlons

(e.g. deoarbox11atl00a) 1n wh1Ch pyridoxal

O~

o\he. appropriate

a14ebyde. and a sultabl. . .tal e.1s ••py• • • oatalyets. It tbua
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s .... that the catalytlc potentlalitles or pyrldoxal phosphate
enzymes are to a large degree tho.e ot their prosthetI0 gr-oup
and that the non-enzymatl0 and enzymatl0 reaotlons proceed by
clo.ely similar mechaniams (42).
In Chapter III, It was ••en that the greatest portlon
of the SGO-T aot1vlty was concentrated In the areas ot the alpha2
globuUna and 1n the area immediately t,ollowlng thi ••erum protein traotion. The Q.ue.tion aro.e aa to whether the act1vit7 1n
thi. tMctlon wa.• due to the ena,.. 1t.elf

01"

whether perhaps the

enzyme had been .eparated tram the coenzyme during the proce.. ot
electpophore.la. ThIs might well be the oa.e 1t the bond between.
the enayme and tbe coenzyme were 10nl0 in nature. It thIs .ere
aotually the

0 ••• ,

the actIvity round 10. the area of the alphas

globulins might .ell be due to nan-enzymat10 transamination by
the pyrldoxal phosphate which could have migrated to this posit-

100. and the ena,.e might be 1n another fpaction, but Inaotivated
by the loa. of the coenzyme. It waa then decided to add pyr1doxal

phosphate to tn. eluted

t~aot1onB

and determine if any of the

other ttt'aotiona would show slgni1'lcantl,. Increased activity by
activation

or

P£!P!£~ti2D

the apoenzyme w1th tn. coenzyme.

.of tao Syple

In this experiment, the electrophoretio .eparations
.ere

ca~ried

out by the same method and under the same condition•

• a d•• cplbed in Chapter III. In thi. oaa., however, the elution
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was carried out with a solutIon of 0.1 M. phosphate bUtter containing the coenzyme, pyridoxal phosphate. Sinoe the

preincubatlo~

time tor the apoenzyme and the ooenzyme have been shown to be
oritlcal, the serum protein tractions which were eluted with the
phosphate butter solution oontaining pyridoxal phosphate .ere
allowed to

~e-incubate

tor one hour at room temperature as pre-

scribed by Meister, Sober and Peterson (40). This pre-incubation

ot one hour was round by these authors to be necessary tor full
aotivation ot the enzyme. A turther pre-incubation ot ten hours
In the refrIgerator at SoC. was al1owe4. The enzymic actIYity ot
the pre-incubated samples was then determined by the atorementioned spectrophotometr1c procedure.
Due to the non-enz,matic transamination by the pyridoxal
phosphate and the low c'onoentratlot1 ot transaminase in the protein
fractiona, several experiments had to be done to

det.~lne

the

proper concentration ot pyridoxal phosphate to be used In the
alution solution. Solutions oontaining 10 and 1 miorograms o£ pyr1doxa1 phosphate per millIliter ot solution, respeotively, were
teatad but the non-enzymatio transamination was so pronounoed that
the enzymatic activIty was completely masked. The aotivity o£ all
of the tractions was greatly, but inoonslstently increased and the
results were not reproduoible. The oonoentration ot elution solution tinally deCided upon was 0.08 micrograms pyridoxal

pho~phat.

per m111iliter (Appendix). Since 1.3 milliliters of the sample
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were used 1n the spectrophotometric reaotion mixture, this gave a
total ooncentration ot 0.1 micrograms of pyridoxnl phosphate 1n
the 3 millIliter ouvette.

Speotral Charaoteristios

or

P;o:idoll:al PhosP!'l!te

A speotrtU'!1 was run on a solution containing 1.3 tnll11liters of the elution solution 1n 1.7 millilIters of the phosphate burrer, but no absorption was shown by thIs concentration
of pyridoxal phosphate over the range of 225 to 425 millimiorons.
A speotrum was also run on a solution oontaining 0.3 millIliters
of reduoed diphosphopy.ridlne nucleotide (O.B milligrams per ml.)
in phosphate burrer, 1.3 milliliters of the buftered solution ot
pyridoxal phosphate (O.OB micrograms per- milliliter) and 1.4 milliliters ot 0.1 M. phosphate burter. Aa seen from Table VI (Appendix), the pyridoxal phospha.te, at the conoentration used in this
experiment, had no effeot on the oxIdation of reduoed CoeM,... I
slnoe the deereal. In optical denSity atter thirteen hours was
tha same within experimental error as that shown in Figure I and

in Table V, in which ca.8 the sample contained only DPNH 1n a
phosphate butter solution. In higher ?oncentl"'ationa, the pyridoxal
phosphate shows charaoteristio absorption over the range ot 225
to 425 millimiorons as seen from r'i&."Ure III and Table VII (Appendix), which represent the absorption of pyridoxal phosphate in a
concentration of 10 mlcrograme per millilIter. '1'he pyridoxal phosphate haa enough 11eht absorption around 400 millimicrons to be
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yellow (46), but it Rlso has a Charaoteristic speotra in the
ultraviolet.
Arter the prote1n traotions were eluted with the bufrered pyridoxal phosphate solutIon (0.08 miorograms per millIliter),
the enzymio aotiv1ty of the samples was determined by the speotrophoto~~trl0

prooedure previously described in Chapter III. A8 seen

trom. Table III and from It'1Bure IV, the non-enzymat1c transamnat1on still offers considerable intex-terence with the enzym.atio trans",
a.inatlon even at the very low oonoentrations of pyridoxal phosphate used here. All of the protein traotions anoved increased
aotivity Which hal been aSlIu.nted to be due to the non-enzymatic
transamination. The position of maXimal aotivity is not appreciably altered here, however, but the dirt.reno. In activity between

the position of mAximal actIvIty and that of the

othe~

proteIn

traotions i8 not a8 d1vergent &8 was observed in Chapter III. In
this experiment. there appeax-s to be slightly more tx-ansaminase
activIty in the alpha g globul1n traction than 1n the area immediately tollowing this proteIn fraction. The reverse was tound to
be true In Chapter III In whlch the samples were eluted with phos-

phate buffer. In either ease. however. the largest concentratIon
of transaminase actIvIty Is associated with the alph&2 globulins
rather than the beta globulIns as previously proposed. SInce the
addItIon of pyridoxal phosphate dId not result in greatly Increased tr9.nsa.minase acti vi ty In any of the proteIn fItaetlons,

TABLE III
'tRA.NSAlSIIASB AOTIVI'l'! OF THE VAftlOUS SERUM PROTEIN
f'f(ACTIOnS A}i'TI-::R THntTEf:N Harms

...

,

..

Aot&,&b:,Ug&t,

-1
1. Albulalna

0.079

a

I,

0.0&6

0.096

4

0.136

0.076

0.177

7. Beta

0.080

0.083

o.oas

0.074

O.OBO

8. Beta to Gazrul.ta

0.0'19

0.090

0.101

0.004

0.098

0.051
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~

0.18 t-

0.1

,l-

(/)

~
z

0.12 f-

~

>f-

0.0 9

>
f-

(.) 0.06
<t

0.03

ALBUMINS ALBUMINS ALPHA-I ALPHA-I

ALPHA-2 ALPHA-2

BETA

BETA

TO

TO

TO

TO

ALPHA-I

ALPHA-2

BETA

GAMMA

}'IGURE IV
TRANSAMINASE ACTIVITY OF THE VARIOUS SERUM
PROTEIN FRACTIONS Al;'TER 'rHIRTEEN HOURS

GAMMA
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the apoanz:rme in the area o.f the nlpha2 globulins vias appa.rently
saturated with the coenzyme and, thus, was not separated fl'om the
coenzyme during the pr008S8 of electrophoresis. These results
would seem to otter further evidenoe tor the hypothesia ot' a nonlonio linkage between the apoenzyme and Its ooenzyme.

CHAPTER V

F'RAOTIONAL PRECIPITATION OF' SI:':RUM PRO'l"'EINS

In 1889,

Hotm8i.te~

wh1t. of the heD'. egg

observed that ovalbumin trom the

o~etalliz.d

in a ooncentrated ammonium

sultate tiltrate trom which the othe. proteln. of tbe egg white
had been precipitated (47).
ution

tJ"ODl

Fo~

be.t results the pH ot the 801-

which orystallisation takes plaoe was found to be near

•• 8 and the t_peratva near 20°C. Ovalbumin prepa~.d by th1.

method and recryatalllzed ••veral tlm.. has been anown to be pure
by immunologic and other ortteria (47).
Albu1a1n may rea411y be orystal11.ed from blood plasma

of the

~ee

by a

salting out procedure similar to that described

tor ovalbumin (47). Moat of the globulins are precipitated at
halt s.turation (about 2 iii.) of lUDlo:niua sulfate. Incroe••e in the

ealt ooncentration precipitate. crystalline albumin•• Thi. materlal, how.ve"., Ie tar trom homogeneous and haa been .eparated into
.ev••al dlst1nct traotlons. The pla ... albumin. of most
speole. have

or

p~ov8d

oth.~

difficult to purity or crystall!.e by meana

salting out. Human serum albumin has b.en crystalli.ed trom

ammoniua aultat. by Kendall (31).

1~.ae

albumins wh1ch had b.en

crystalll.ed tour time. were still colored yellow by the pr•• ence

ot .e:rum plgment •• The

o~atallln.

human serum albumin 18 a ••oe-

iated with. small amount ot tree fatt7 aold that cannot be re-

S3

moved without .flrst denaturing the albumin (11). SolubilIty
meaaure.ent. by KendaU Ind10ated that the crystalline human aera

albumin 1. more homogeneous than the COrl"'8spondlngalbum1n 115-

olated from hor.. .erum.
Cholet ot Prtg&pl\1,iB& ABIO!
Fftotionatlon by means ot olting out 1. inherently 1•••

powerful than the methods of ••parat10n at low 10nl0 strength,
either 1n water or in aqueous ethanol. Neurath (47) points out.
however, that the dellcat. protelna are le •• l1kely to .urter
4"-6- in the pre.ence ot neutral salt. than in the pre.ence ot

organio sol.,ents and that the salting out method i . Nat1vely
more aimpl. and convenient to oarry out wlthout special skill and
equipment.

AmMonium saltat. haa been w14ely us.d .a a .alting out
agent, sinoe it haa a hlgh solubility and roushly neutral reaction
,

(pH 5 to 6) In concentrated solut1on (46). In alightly alkal1ne
solution, ."en at pII 9.3, tlfty per oent of the ammonium lon haa
already b.en

conye~t.4

to ammonia. The pH ot ammonium aulf'ate .01-

ut10ns should be controlled by .eana of a butter. The l1m1ted sol-

ubillty ot sodium sultate tends to restriot Ita use. However, 1t
1t 1s us.d, oare mult be exercised to carry out une operat1ons
above

saGe.

in oPder to avold crystallization ot the decah,-drate.

Potassium phosphate butters ot known ionic strength and pH are
etteot!ve but are not soluble enough tor

0.01"7

need. Sodium chlor-
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ide, magne.ium lultate and aodium acetate hay. all been used to •

l ••••r extent.

Th.~.

1. little information about d1rferenoes amon

the Yarioua aalta with regard to po.aible speoiflc .ttftct. on prote1n precipitation or crystallization.
~ro22s.~ ~I0h!nl!! ot"Salt~ns

Oui"

The mechllniam ot salting out 1. undoubtedly highly oom-

plex. It baa been Bugge.ted that It was due to dehydration

or

the

protein by the added a.lt. Aocordlng to the view developed by
Debye (le). the salt 10n. attract the polarizable water moleoule.
around th ....lv •• to a y.r1 large extent, making leas water available tor the proteina aince, at high aalt concentrations, the number of charged groupa oontributed bY' the salt 1s large compared
wIth tho •• by tbe proteins. Since 801ubility ot the protelna 1n

water 18 thought to depend on the olu8tering ot water molecul ••
around the hydrophilio 10nlc group., removal ot water molecules to
other ions w111 decrea •• the protein solubillty_
All the proteins studled have been found to be prec1pitated f:rom aClusous .olutior!

by hl!~h

concentrations of neutral

salt•• The .Etectlve reglon ot .alting out 1s usually at very high
ooncentratlons and 1a most etfeot1ve at the 18081eotr10 poInt

or

the proteln. SaltIng out has been round to oocur not only with
protelns but w1 th gasea, uncharged molecules. and eleotrolytoa.
~r801nltatlgn

Prooedy£!

In tb1s exper1ment. ammonlum sulfate was used as the
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precipitating
WI

a.~.nt

to obtain a

pa~tlal

traotlonatlon ot tbe ••r-

protelns Into the albwRln and slobulJ.n tl'aotlons. The

let'WI.

used was tram human blood sino. . .latlve17 large quantttl•• we. .
nec •••ary to!' t'Paotlonatlon. The . . .p1e. were twent,.-tour boUl' old
••tta

obtained trOl1 nektoen Inatltute. whlah bad been kept refrig-

erated until ready tor u •••
In the preoipltation, 5.0 Jdll1l1te.a ot 41.tI1184 water

was added to 5.0 ld.lll1ttera of' the serum In a pl.st1c cent..ltug_
tube (50 .tl1111t... yolume). To tb1. waa added two

~pa

or 0.6 N.

sulfuric acid '.6). Att..,.- Jd.x1n.g the _pl•• , 10 m11UUte••

or

a

aatul"atod solutton of' 4l1mOnl_ aultate ( •• 10 M. at 26°0.) .U add-

ed 8lowly wItb oontlnuou8

.tl~lng

and the solutton was

allow~

to

atand tor 20 II1nuha w1 th oce•••tonal 8t1.1'1ns. The solution was
them centl"lt'ugGd top SO Jd.nut•• and the _pernat8nt waa 4eoanted
and ..vad tor the late p"0Ip1'at10n

Tba pl'eolpltate4

HIlUm

or the albualne.

globulin••8 " tben "",di ••olved

1n the plastl0 oentr1fuge tube witb 8.0 m111111t... of d1.'111.4
water. To thi. wa. added 9.0

~11111t.1'8

ot the aaturated ammon-

lum sulfate solut10n wltb oontlououa at1JlPlng ... bet.... Arte.

boing allowed to .'and tor ano\hep 10 adDut•• with ocoaa.lonal
atlrrlng, tn. solutton was agaln

o.nt~ltuged

ro.

20 minut... The

supernatant ..8 decantod and disoarded. The precipitated globulins were d18801vod 1n 9.0 Dd.lllUtera

To the eupernatant

~om

or

0.1 M. phosphate butt•••

the tirat pnolpltatlon of.' the

globulins, solld ammon1um sulfate (approximately 7 grams) was added with constant
the •• It. The

.tl~lng

until the solution wns sa.turated wIth

solutIon waft allowed to stand. tor 30 minutes with

trequent stiwing. It was then flltered throuyft V..1latman No.1
tilter paper aince it was round that the albumins would not came

down In the

cent~ltug ••

The preoipitated albumins W$re then re-

d18s01ved in 4.0 mtlUllteps of 0.1 M. phosphate butter of pH 7.4_
The soluttons of ••x-um album1ns an.d elobulins wore transfe1"l"ed to 410.1:1818 bags made trOJrll A. H. Thomas dialysis tubing

ilo. 4465-A2. The two solutions we,...., then dialyzed in separate one

llt.r solutions ot 0.1 M. phosphate burrel' (pH 7.4) for 20 hours
in the deep tx-&e • ., at ,0C. with oonstant stirring b;r the Magna
St1r, llUulutactuped by Labol'la.totty Industries, Inc. J Chicago, 111-

inola. Sinoe h ••t 1. generated by the

stl~erJ

preoautions were

taken to insure constant temperatul'le or the dinlyslg solutIon by
placIng aab.sto. mats, •• parated by an air layer, between the
stIrrer and the solutions and by o1rculating

th~

a1r 1n the deep

tr•••• w1th a _11 tan.

Atter the d1alysls. tbe solutIons were transferred
quantItatIvely to 25 m111111ter volum.tric tlssks and diluted to

voluae wIth 0.1 M. phosphate butter. The
the two fractIons was then

dete~lned

trans~m1n~se ~et1vity

by the

8peetro~hotometrle

1'1'oeedur., desor1b.d earlier.
S'Qutr<mbatm:mtr1g Analystl

or ;EnIDI

Ac~1x1t%

ot
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In this analys18, 0.5 millillters of the 0.2 M. 1-

aspartate was added to a 3 millI11ter cuvette and to this was
added 0.1 milllUter of the malic dehydrogenase, 0.3 mtl11l1tell

of the reduced dlphosphopyrldine nucleotide solution. a 1.5 millilIter aliquot of the tractionated serum protein sample and 0.4
milliliter of 0.1 M. phosphate burrell. The rererence cell contain8d all of the foregolng constltuents except the reduced Coenzyme
I, which was Ilepla.ed by 0.3 milllliter of 0.1 14. phoaJ)hate butter.
Atter • 30 minute incubation period at room temperatur., 0.2 mll1iltter ot the 0.1 M. alpha-ketoglutarate was added to the reaction
mixture •• (Dilloetian. tor reagents in appendlx). The reduction 1n
optical density was then followed for 90 minute. in the Beckman
DU Spectrophotometer to determine the activity ot the two tract-

ions. The relatty. actlvltl •• of the two protein tractions are
shown in Table IV and In Figulle V. In thIs ea.e the largeat part
ot the transamina•• aotivity 18 concentrated In the albumin tract10n wIth a small amount of activIty in the globulins.

The d1fter-

ence between the activity 1n the globulln and the albumin tract10n. is statistically signiticant as indicated by the large t-

value obtained. The t-valu.e 1. calculated on the basia or the
standard error of the ditterenoe of two meana.
That the tNUlaaminaa. i8 not .8'P8rated trom 1 ta coenzyme
during the tractional J)x-ecip1tatlon 1s indicated by the relatively
large amount ot enzymatic actIvity in the albumin fraotion.

TABLE IV
REDUCTION IN OP'I'ICAL DRtiSITY CAUSED BY THE ALBUMIN AND CLOBtJLI1'4 FRAC1'IONS
OF 0.3 MILLILI~ER HUMAN SERUM SAMPLES OVER A 90 MINUTE PERIOD AT ROOM

TEMPERATURE

GLObULINS

Sample

Pacreaae
1n OD

Mean

Standard
Deviation

0.059

-

0.054

No. 1
0.064

0.062

No. 2

ALBU1UUS

0.063

±

Standard Standard
Deviation
Error

0.251

-+ 0.035

0.0255

7.7

0.269

-

+ 0.008

0.0062

33.2

0.365

-

0.0211

0.2'16

0.002
0.275

0.073
0.075
0.077

Mean

±

t

Value

0.226

+ 0.007

0.065

No. 3

Decrease
1n OD

0.344
0.003
0.386

58

+ 0.030
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~

Z
Z

0
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0,10

-

0
W
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01.0BULINS
GLOBULINS
GLOBULINS
ALBUMINS
ALBUMINS
ALBUMINS

NO,I

NO.2

NO.3

F'IGtJRE V
REDUCTIO!: XU OPTICAL DENSITY CAUS:&'1) BY THE ALBUlO:!1 AND

GLOBULIN F'RACTIONS OF I!UMAN SERUM OVER Po 90 'MINUTE

PIlUOD

CHAPTER VI

SUlGiARY AND CONCLUSIONS

The enaymatio activity of glutamic oxalacotl0 transaminas. baa been found In serum both 1n the normal and patholOg10al atat••• Th. corullstently elevated lev.ls of th18 enz". 1n
.erum dur1ng pathologies involvIng necros1s of transaminase rich
tissues. partIcularly cardIac muscle and liver tissue, has re.
sult.« In widespread investigation of the c11n1cal implications
ot this anomaly. The objective of this relearch. however, bas
been to pre.ent a further bioohemical charaoterization or the
enz,.. tram the point of view of It. eleotrophoretio mdgratlon
pattern, ita tractIonal preoipitation properties and the natu"
ot the linkage betw••n the

.nz~

and ita coenzyme, pyr1doxal

phosphate.
By a combination ot the horizontal paper strip method
ot tonography de8cribed by MoDonald at al (39) and the speotrophotometric prooedure tor tne determination of glutamic oxalacetio
transaminase actIvity by Karman (28). the enz,me was found to b.
asaociated with the alPbaa globulins

or

the .erum. The maximal

aotivity waa located 1n the are. immediately tollowlng the alPbaa
globulins with slightly le88 act1vity in the alphf12 traction it.elt.
The question then arose as to Whether the actIvIty 1n
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thi. afle" wa. due to the enzyme itselt or whether perhaps the

aoo.i' had been .eparated from the coenzyme

dUl"ing the proce •• ot

electrophoresi., which

m1~~t

betw••n the enzyme

the coenzJ!!le is of an ionic rather than a

And

well be the ca •• if the linkage

non-ionio nature. It this were true, the aotlvlty seen 1n the ••
ape.s may ".11 have been due to non-enzymatic transamination by
the pyroidoxal phosphate which may have migrated to this post tion
and tbe enzyme may have been 1n another traction but inactivated
by the loas of the coenzyme. Pyridoxal phosphate was then added

to the speotrophotometric reaction mixture. to determine It any

or

the other traction. would show .ignlfioantly increased activ.

1ty by aotivation ot the apoen.,.. with the coena,.e. The area ot

maximal actlvity was not ohanged, however, by the additlon of the
coenzyme. In this cae. the alphag globulIns contained the maximal
actlvIt7 w1th slIghtly lee. activIty In the are. immediately trail
ing this serum prote1n fraotion. Since the additlon or pyrIdoxal
phosphate dId not result 1n gr••tly Increa.ed act1vity In any

or

the other fractions, the apoenzyme 1n the vicinity of the alphaS
globullns was apparently supplied wlth the coenzyme and, thus, was
not separated from the coenzyme durlrtg the process of electrophoresis. These results would .eem to otfer i'U%'tht'tr evidence tor the

hypothes1s of a non-1onic IInkllgo between the apoenzym.e and its
coenzyme.
In the fractional precipitation of the serum proteina to
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determine with which fract10n the trsnsaminaa6 was a.sociated,
the proteins were removed from solution by the process known as
U
salting "
out •

using ammonium sulfnte as the preolp1 tatlnp, agent.

Significantly more activity was found in the

albQ~1n

than In the globulins as denoted by the large t-value

Th. transaminase

ap~arently

fraction
obt~lned.

is not separated trom the pyridoxal

phosphate during the preoipitation prooedure sinoe there is a
relatively larhe
traction.

a~ount

of transaminase activity in the albumin

APPEliDI)..
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REAGENTS

1. Alpha-ketoglutarate, 0.1 M.
DI ••olved 1.47 grams alpha-ketoglutaric acid (Sigma
Chem. 00., St. Louis, Hissouri. K56-63) in 70 milllliters
phosphate but"f'er solution (No.5). Adjusted to

pH 7.4

wlth

1 N. HaOM (approxlmately 20 milliliters) and diluted to 100
ml11ilitor. wlth phosphate butter. Kept tro•• n.
2. l-Aapartate, 0.2 M.

Dlsso1ved 2.662 grams
Blochemioal Corp.,
390067)

F~:r.ehold,

l-a.p~!c

aold (Worthlngton

lle. Jerse,., Mathe.on 5950-

in 70 m1111Uter8 phosphat. butter solution (No.5).

A.dJusted to

pH 7.4

with 1 N. BaOH (appro.x1mately 20 milll-

litera). Diluted to 100 ml11l11ter8 wlth phosphate butter.
Kept fro.en.
3. Bros Phenol Blue Stain.

Di.solved 2.0 gram. Brom Phenol Blue In 190 milliliter.

ot 95 per oent ethanol saturated with mercuric ohloride. Adde4 1.0 milliliter ot glaoial acetic ao14, mixed and flltered.
4. Malle Dehydrogenase (50 micrograms per mill!l! tor) •

Dlluted 0.20 milll1iter ot malic dehydrogenase (2.5
milligrams per millilIter, Vforth1ngton Bioohemical Corp.,
Freehold, New Jersey, MA5514) to 10.0 milliliters wlth phos-
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phate butfer solution (No.5). Kept refrigerated at SoC.
5. Phosphate Bufter, 0.1 M., pH 7.4.
Di.solved 13.97 grams anhydroua K2HP0 4 and 2.69 gram.
anhydrous KH 2P0 4 in distIlled water and diluted to 1 liter.
Kept refrigerated at

soc.

S. Pyridoxal Phosphatee

Sol. Xl Dissolved 4. milligrama pyridoxal-5-phosPhateeU 20
(Californ1& .r'oundat1on for Biochemioal Reaearch, Loa Angel.a,
California, Lot 1.50892) in 10.0 millIliters phosphate butter
(No.5)

e

Sol. II: Diluted 0.2 milliliter Sol. I to 100 milliliters with phosphate burrer (No.5). This gives a concentration of 0.8 micrograms pyridoxal phosphate per milliliter.
Sol. III: Diluted 10 milliliters Sol. II to 100 millilIters with phosphate butfer 0;0. 5). This gives a conoentration of 0.08 miorograms pyridoxal phosphate per milliliter.
Kept all pyr1doxal phosphate solutiona refrIgerated at SoC.
7. Reduoed Diphosphopyridine Nucleotide,

o.a

milligram per milli-

liter.
Dissolved 4 mll11erams ot reduced dlplloapbopyrid1ne
nucleotide (Slgma Chem. Co., St. Louis, Missouri, Lot 108-110)
In 5 milllliters phosphate burrel' solution (Uo. 5). Kept retrig.rated at 5oC.
8. Veronal Burrer, 0.0'172 M." pH 8.9, ionlc strength ot: 0.0'1.
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Dissolved 2.80 grams dlethylbarblturlc aoid and 28.68
grams sodium dlethylbarblturate 1n distilled water and diluted
to 2 liters.
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THE

AbSORP~rIOH

SPECTRA OP' REDUCED DIPHOSPHOPYRIDINE

NUCLEOTIDE (approximately 0.08 mg./ml.) Hf 0.1 MOLAR
PHOE;PHA'1'E BUJ.'F'ER

Wave Length
(mu)

OPTICAL DENSITY

At Tim.e

After 13

450

0.001

0.004-

445

0.002

0.00.&

'"0

0.002

0.004:

435

O.ooa

O.()(M

430

0.008

0.004

425

0.002

0.004

420

0.001

0.003

415

0.002

0.004

410

0.004

0.004

405

0.006

0.004

400

o.au

0.011

395

0.022

0.020

390

0.038

0.036

385

0.065

0.059

S80

0.108

0.094

375

0.162

0.137

Zero

Soups

TABLE V (continued)
Wave Length
(mu)

OPTICAL DENSITY

At T ill'le

Atter 13

z.~o

Hour.

370

0.22S

0.190

365

0.287

0.245

360

0.355

O.SOO

355

0.419

0.354

350

0.462

0.395

345

0.495

0.422

340

0.511

0.430

335

0.500

0.425

330

0.475

0.401

325

0.435

0.367

320

0.380

0.325

315

0.325

0.281

310

0.269

0.243

305

0.219

0.224

300

0.181

0.228

295

0.154

0.251

a90

0.148

0.304

285

0.196

0.390

280

0.364

0.580

275

0.649

0.865
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TA3LE V (continued)
OPTICAL DE1{SITY

Wave Length
(mu)

At Time

After 13

270

1.020

1.241

265

1.305

1.492

260

1.412

1.561

255

1.325

1.453

250

1.120

1.198

245

0 .. 880

0.920

240

0.700

0.720

236

0.620

0.619

230

0.640

0.621

225

0.7'12

0.740

4ero

Hours
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TABLE VI
THE ABSORPTION SPEC'l'RA Of' REDUCED DIPHOSPHOPYRIDINE
NIJCLhOl*IDE (approximately 0.08 mg./ml.) IN 0.1 MOLAR
PHOSPHATE BUf'F'ER CON'rAINnm 0.04 l!ICROGHAMS PYl{IDOXAL

FIfOS-FHA'I'E: PER MILLILITER

Wave Length

OPTICAL DEllSITY

At Time

Atter 13

450

0.000

0.005

445

0.001

0.006

440

0.001

0.006

430

0.000

0.006

420

0.003

0.007

410

0.003

0.007

400

O.OU

0.014

395

0.082

0.024

390

0.038

0.039

385

0.065

0.061

380

0.106

0.097

175

0.156

0.138

1'10

0.219

0.190

365

0.283

0.245

360

0.350

0.299

(mu)

Zero

Hours
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TABLE VI (oontinued)
Way. Length
(mu)

OPTICAL DENSITY

A t Time

After 13

Zero

Hours

355

0.417

0.350

350

0.461

0.35010

345

0.492

0.418

340

0.513

0.425

336

0.496

0.421

330

0.470

0.397

325

0.431

0.364

320

0.376

0.323

315

0.320

0.280

310

0.265

0.243

305

0.215

0.224

300

0.1'18

0.230

295

0.152

0.260

290

0.146

0.308

285

0.193

0.395

280

0.359

0.582

2"15

0.542

0.865

270

1.015

1.231

265

1.300

1.487

260

1.408

1.558

72

TABLE VI (continued)
Wave Leneth
(mu)

OPTIOAL DENSITY
After 13
Zero
Hour.

At Time

255

1.320

1.424

250

1.117

1.193

245

0.875

0.920

240

0.695

0.721

235

0.515

0.622

230

0.637

0.629

225

0.769

0.742
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TABLE VII
'l'HE ABSORPTION SPECTRUM Or' PYRIDOXAL PH03PHA'1'E (10 micrograms per milliliter) IN 0.1 M. PHOSPHATE BUFf'ER SOLUTION

Wave Length

(mu)

Optical

Den.tty

Wave Length
(mu)

Optical

nen.tty

450

0.015

360

0.293

445

0.025

355

'0.259

440

0.041

350

0.228

.35

0.066

348

0.119

410

0.099

345

0.207

42e

0.144

343

0.203

410

0.196

340

0.200

415

0.256

338

0.200

410

0.307

335

0.203

405

0.356

333

0.205

400

0.396

330

0.208

395

0.422

328

0.a08

390

0.434

325

0.206

385

0.432

323

0.202

380

0.420

320

0.192

375

0.396

318

0.184

370

0.365

315

0.169

365

0.330

313

0.158

7.
TABLE VII (oontinued)
Wave Length

Optical
Density

Wave Length

Optical
Density

310 .

0.142

270

0.120

308

0.130

B65

0.141

aotS

0.115

260

0.196

303

0.108

255

0.254

300

0.095

250

0.310

295

0.079

245

0.400

290

0.076

240

0.634

285

0.080

235

0.865

280

0.090

230

0.9'10

275

0.10~

225

1.029

(mu)

(mu)
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